• Therapies and Medications

  Parkinson’s vaccine seen to target toxic alpha-synuclein in Phase 1 trial

  Posted by ajs1 on July 26, 2024 at 8:06 pm

  Seems like I found this in this forum. looks like if they need patients for clinical trials this membership is full of them!!!!

  https://parkinsonsnewstoday.com/news/parkinsons-vaccine-targets-toxic-protein-phase-1-trial/

  

  parkinsonsnewstoday.com

  Parkinson's vaccine seen to target toxic protein in Phase 1 trial

  UB-312, an experimental Parkinson's vaccine by Vaxxinity, reduced damaging clumps of the alpha-synuclein protein in treated trial patients.

  ajs1 replied 9 months, 2 weeks ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply